Arias, Cesar Augusto
- Houston Methodist Research Institute (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #5,323
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1.6M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#5,323
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Arias, Cesar Augusto as a PI. Multi-PI records show the full award amount for context.
- 5R01AI148342-04R01Contact PIVENOUS: A translational study of enterococcal bacteremia$774.8Kaward amount
- 1R01AI173138-01A1R01Contact PIClinical Impact of the Cefazolin Inoculum Effect$687.7Kaward amount
- 5K24AI121296-08K24Contact PIPOR and Training Program on Multidrug-Resistant Organisms$126.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Arias, Cesar Augusto as a PI.
FY2023 award administered by Houston Methodist Research Institute (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardHouston Methodist Research Institute
- 2010$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2013R01 Grant Holder
- 2014$2M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #9596
- 2019$5M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #1744
- 2020Entered Top 10% NationallyRanked #1744
- 2021$10M Cumulative Funding